Publications

Clark K, Crooks K, Jeyanathan B, Ahmed F, Kataquapit G, Sutherland C, Tsuji LJ, Moriarity RJ, Spence ND, Sekercioglu F, Liberda EN, Charania NA. Highlighting models of Indigenous leadership and self-governance for COVID-19 vaccination programmes. AlterNative: An International Journal of Indigenous Peoples 2024. doi:10.1177/11771801241235418 . [Abstract]

Shrestha AC, Field E, Thangarajah D, Andrews R, Ware RS, Lambert SB. Influenza epidemiology and vaccine effectiveness following funded influenza vaccine in Queensland, Australia, 2022. Influenza & Other Respiratory Viruses 2024;18:e70007. doi: 10.1111/irv.70007. [Full text]

Wang X, Patel C, Giles ML, Burns P, Macartney K, Teh B, Williams PC. Glucocorticoid dosing and implications for vaccination: evolution of global definitions. Clinical Infectious Diseases 2024:ciae613. doi: 10.1093/cid/ciae613 . [Full text]

Misan A, Lambert SB, Phung H, Young MK. Evaluation of the Queensland JEV vaccine program response to the 2022 Australian outbreak. Epidemiology & Infection 2024;152:e176. doi: 10.1017/S0950268824001730. [Full text]

Mazzocato P, Leder K, Deng L, Britton PN. Travel-associated illness in children in pre-pandemic Western Sydney, 2018-2020. Public Health Research and Practice 2024;34:3432422. doi: 10.17061/phrp3432422. [Full text]

Patel C, Vette K, Dalton L, Dey A, Hendry A, Hull B, McIntyre P, Macartney K, Beard F. Assessment of the first 5 years of pharmacist-administered vaccinations in Australia: learnings to inform expansion of services. Public Health Research and Practice 2024;34:3432420. doi: 10.17061/phrp3432420. [Full text]

Tinessia A, Clark K, Randell M, Leask J, King C. Strategies to address COVID-19 vaccine hesitancy in First Nations peoples: a systematic review. Global Health Action 2024;17:2384497. doi: 10.1080/16549716.2024.2384497. [Full text]

Loe MW, Soenong H, Lee E, Li-Kim-Moy J, Williams PC, Yeo KT. Nirsevimab: alleviating the burden of RSV morbidity in young children. Journal of Paediatrics and Child Health 2024;60:489-498. doi: 10.1111/jpc.16643. [Full text]

McDonald E, Pittet LF, Barry SE, Bonten M, Campbell J, Croda J, Croda MG, Dalcolmo MP, Davidson A, de Almeida E Val FF, Dos Santos MG, Gardiner MK, Gell MG, Gwee A, Krastev MA, Lacerda MVG, Lucas M, Lynn DJ, Manning L, McPhate MN, Perrett KP, Post JJ, Prat-Aymerich C, Quinn MLE, Richmond PC, Wood NJ, Messina NL, Curtis N; BRACE Trial Consortium Group. Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial. Journal of Infection 2024;89:106267. doi: 10.1016/j.jinf.2024.106267. [Full text]

Reynolds R, Tay E, Dymock M, Deng L, Glover C, Lopez LK, Huang YA, Cashman P, Leeb A, Marsh JA, Snelling T, Wood N, Macartney K. Short-term active safety surveillance of the Spikevax and Nuvaxovid priming doses in Australia. Vaccines 2024;12:971. doi: 10.3390/vaccines12090971. [Full text]